Temporal ordering of cognitive impairment in Parkinson's disease patients based on disease progression models.

Autor: Platero C; Health Science Technology Group, Technical University of Madrid, 28012, Madrid, Spain. Electronic address: carlos.platero@upm.es., Pineda-Pardo JÁ; HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain; Instituto de Investigación Sanitaria HM Hospitales, Spain.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 Oct 21; Vol. 129, pp. 107184. Date of Electronic Publication: 2024 Oct 21.

Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease.

Autor: Martínez-Fernández R; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Natera-Villalba E; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Máñez Miró JU; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Rodriguez-Rojas R; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Marta Del Álamo M; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Pineda-Pardo JÁ; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Ammann C; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Obeso I; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain. jobeso.hmcinac@hmhospitales.com., Mata-Marín D; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Hernández-Fernández F; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Gasca-Salas C; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Matarazzo M; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Alonso-Frech F; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain., Obeso JA; From the HM CINAC (Centro Integral de Neurociencias Abarca Campal) (R.M.-F., E.N.-V., J.U.M.M., R.R.-R., M.D.A., J.A.P.-P., C.A., I.O., D.M.-M., F.H.-F., C.G.-S., M.M., F.A.-F., J.A.O.). Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid; CIBERNED (R.M.-F., R.R.-R., J.A.P.-P., I.O., C.G.-S., J.A.O.), Instituto Carlos III, Madrid; San Pablo-CEU University Medical School (R.M.-F., J.A.O.), Madrid, Spain. J.U.M.M. is currently at the Department of Neurology, IMED Hospitales, Valencia and the Universidad Autónoma de Madrid University-Instituto Cajal, Madrid, Spain. jobeso.hmcinac@hmhospitales.com.

Publikováno v: Neurology [Neurology] 2023 Mar 28; Vol. 100 (13), pp. e1395-e1405. Date of Electronic Publication: 2023 Jan 11.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

Autor: van Eimeren T; Multimodal Neuroimaging, Department of Nuclear Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne, Germany.; German Centre for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany., Antonini A; Department of Neuroscience, University of Padua, Padua, Italy., Berg D; Department of Neurology, UKSH, Campus Kiel, Christian-Albrechts-University, Kiel, Germany., Bohnen N; Division of Nuclear Medicine, Department of Radiology, University of Michigan, and VAMC, Ann Arbor, MI, USA.; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.; VAMC, Ann Arbor, MI, USA., Ceravolo R; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Drzezga A; Multimodal Neuroimaging, Department of Nuclear Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne, Germany.; German Centre for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany.; Forschungszentrum Jülich, INM-2, Jülich, Germany., Höglinger GU; German Centre for Neurodegenerative Diseases (DZNE), and Technical University Munich, Department of Neurology, Munich, Germany., Higuchi M; National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan., Lehericy S; Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, ICM Team 'Movement Investigations and Therapeutics', Sorbonne Universités, Inserm U1127, CNRS UMR, Paris, France., Lewis S; Brain & Mind Centre, Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Monchi O; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.; Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Nestor P; Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.; Mater Hospital, South Brisbane, QLD, Australia., Ondrus M; AXON Neuroscience CRM Services SE, Bratislava, Slovak Republic., Pavese N; Newcastle Magnetic Resonance Centre & Positron Emission Tomography Centre, Newcastle University, Newcastle upon Tyne, United Kingdom., Peralta MC; Center for Medical Education and Clinical Research, Section of Neurology, Buenos Aires, Argentina., Piccini P; Department of Medicine, Imperial College London, London, United Kingdom., Pineda-Pardo JÁ; hmCINAC, University Hospital HM Puerta del Sur, CEU-San Pablo University, Móstoles, Madrid, Spain., Rektorová I; First Department of Neurology - Faculty of Medicine and CEITEC MU, Masaryk University, Brno, Czech Republic., Rodríguez-Oroz M; Department of Neurology, Clinica Universidad de Navarra, Pamplona, Spain., Rominger A; Department of Nuclear Medicine, Inselspital, Universitätsspital Bern, Bern, Switzerland., Seppi K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Stoessl AJ; Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, Canada., Tessitore A; Department of Medical, Surgery, Neurological, Metabolic and Aging Sciences, University of Campania, 'L. Vanvitelli', Caserta CE, Italy., Thobois S; Université de Lyon, Université Claude Bernard Lyon 1, Faculté de Medecine Lyon Sud Charles Merieux, Lyon, France.; Hospices Civils de Lyon, Hopital Neurologique Pierre Wertheimer, Neurologie C, Lyon, France.; CNRS, Institut des Sciences Cognitives, Bron, France., Kaasinen V; Department of Neurology, University of Turku, Turku, Finland.; Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland., Wenning G; Division of Clinical Neurology, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Siebner HR; Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark., Strafella AP; E.J. Safra Parkinson Disease Program, Toronto Western Hospital & Krembil Research Institute, UHN, Toronto, Ontario, Canada.; Research Imaging Centre, Campbell Family Mental Health Research Institute, CAMH, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Publikováno v: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2019 Apr 02; Vol. 11, pp. 301-309. Date of Electronic Publication: 2019 Apr 02 (Print Publication: 2019).

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Autor: Strafella AP; Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Neurology Div/Dept. Medicine, Toronto Western Hospital, UHN; Krembil Research Institute, UHN; Research Imaging Centre, Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Ontario, Canada., Bohnen NI; University of Michigan & Veterans Administration Medical Center, Ann Arbor, Michigan, USA., Perlmutter JS; Neurology, Radiology, Neuroscience, Physical Therapy & Occupational Therapy, Washington University in St. Louis, St. Louis, Missouri, USA., Eidelberg D; Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA., Pavese N; Newcastle Magnetic Resonance Centre & Positron Emission Tomography Centre, Newcastle University, Campus for Ageing & Vitality, Newcastle upon Tyne, United Kingdom., Van Eimeren T; Multimodal Neuroimaging Group-Department of Nuclear Medicine Department of Neurology-University of Cologne, Institute of Neuroscience and Medicine, Jülich Research Center, German Center for Neurodegenerative Diseases (DZNE), Germany., Piccini P; Neurology Imaging Unit, Centre of Neuroinflammation and Neurodegeneration, Division of Brain Sciences, Hammersmith Campus, Imperial College London, United Kingdom., Politis M; Neurodegeneration Imaging Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Thobois S; Hospices Civils de Lyon, Hopital Neurologique Pierre Wertheimer, Université Lyon 1; CNRS, Centre de Neurosciences Cognitives, UMR, 5229, Lyon, France., Ceravolo R; Department of Clinical and Experimental Medicine, Movement Disorders and Parkinson Center, University of Pisa, Italy., Higuchi M; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan., Kaasinen V; Division of Clinical Neurosciences, Turku University Hospital; Department of Neurology, University of Turku; Turku PET Centre, University of Turku, Turku, Finland., Masellis M; Cognitive & Movement Disorders Clinic, Sunnybrook Health Sciences Centre; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada., Peralta MC; Movement Disorder and Parkinson's Disease Program, CEMIC University Hospital, Buenos, Aires, Argentina., Obeso I; Centro Integral de Neurociencias (CINAC), Hospitales Madrid Puerta del Sur & Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Pineda-Pardo JÁ; Centro Integral de Neurociencias (CINAC), Hospitales Madrid Puerta del Sur & Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Cilia R; Parkinson Institute, ASST Gaetano Pini-CTO, Milan, Italy., Ballanger B; INSERM, U1028; CNRS, UMR5292; Lyon Neuroscience Research Center, Neuroplasticity & Neuropathology of Olfactory Perception Team, University Lyon, France., Niethammer M; Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA., Stoessl JA; Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, University of British Columbia & Vancouver Coastal Health, Vancouver, British, Columbia, Canada.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2017 Feb; Vol. 32 (2), pp. 181-192. Date of Electronic Publication: 2017 Feb 02.

Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.

Autor: Canuet L; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), leocanon2002@gmail.com., Pusil S; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain., López ME; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)., Bajo R; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)., Pineda-Pardo JÁ; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), CINAC, HM Puerta del Sur, Hospitales de Madrid, Móstoles, 28938 Madrid, Spain., Cuesta P; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Department of Basic Psychology II, School of Psychology, Complutense University of Madrid, 28040 Madrid, Spain., Gálvez G; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Instrumentation and Applied Acoustic Research Group, 28031 Madrid, Spain., Gaztelu JM; Department of Experimental Neurology, Ramon y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, 28034 Madrid, Spain, and., Lourido D; Department of Neurology, Ramon y Cajal University Hospital, 28034 Madrid, Spain., García-Ribas G; Department of Neurology, Ramon y Cajal University Hospital, 28034 Madrid, Spain., Maestú F; Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Madrid Polytechnic University and Complutense University of Madrid, 28223 Madrid, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Department of Basic Psychology II, School of Psychology, Complutense University of Madrid, 28040 Madrid, Spain.

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2015 Jul 15; Vol. 35 (28), pp. 10325-30.